280 related articles for article (PubMed ID: 23371292)
21. Nicotine metabolism and CYP2A6 activity in a population of black African descent: impact of gender and light smoking.
Mwenifumbo JC; Sellers EM; Tyndale RF
Drug Alcohol Depend; 2007 Jun; 89(1):24-33. PubMed ID: 17161559
[TBL] [Abstract][Full Text] [Related]
22. CYP2A6 genotype but not age determines cotinine half-life in infants and children.
Dempsey DA; Sambol NC; Jacob P; Hoffmann E; Tyndale RF; Fuentes-Afflick E; Benowitz NL
Clin Pharmacol Ther; 2013 Sep; 94(3):400-6. PubMed ID: 23714690
[TBL] [Abstract][Full Text] [Related]
23. Duplications and defects in the CYP2A6 gene: identification, genotyping, and in vivo effects on smoking.
Rao Y; Hoffmann E; Zia M; Bodin L; Zeman M; Sellers EM; Tyndale RF
Mol Pharmacol; 2000 Oct; 58(4):747-55. PubMed ID: 10999944
[TBL] [Abstract][Full Text] [Related]
24. Ethnic differences in nicotine metabolic rate among New Zealanders.
Lea R; Benowitz N; Green M; Fowles J; Vishvanath A; Dickson S; Lea M; Woodward A; Chambers G; Phillips D
N Z Med J; 2005 Dec; 118(1227):U1773. PubMed ID: 16372023
[TBL] [Abstract][Full Text] [Related]
25. Interindividual variability in nicotine metabolism: C-oxidation and glucuronidation.
Nakajima M; Yokoi T
Drug Metab Pharmacokinet; 2005 Aug; 20(4):227-35. PubMed ID: 16141602
[TBL] [Abstract][Full Text] [Related]
26. Variation in trans-3'-hydroxycotinine glucuronidation does not alter the nicotine metabolite ratio or nicotine intake.
Zhu AZ; Zhou Q; Cox LS; Ahluwalia JS; Benowitz NL; Tyndale RF
PLoS One; 2013; 8(8):e70938. PubMed ID: 23936477
[TBL] [Abstract][Full Text] [Related]
27. Gene-gene interactions between CYP2B6 and CYP2A6 in nicotine metabolism.
Ring HZ; Valdes AM; Nishita DM; Prasad S; Jacob P; Tyndale RF; Swan GE; Benowitz NL
Pharmacogenet Genomics; 2007 Dec; 17(12):1007-15. PubMed ID: 18004205
[TBL] [Abstract][Full Text] [Related]
28. Effect of UGT2B10, UGT2B17, FMO3, and OCT2 genetic variation on nicotine and cotinine pharmacokinetics and smoking in African Americans.
Taghavi T; St Helen G; Benowitz NL; Tyndale RF
Pharmacogenet Genomics; 2017 Apr; 27(4):143-154. PubMed ID: 28178031
[TBL] [Abstract][Full Text] [Related]
29. Low Cotinine Glucuronidation Results in Higher Serum and Saliva Cotinine in African American Compared to White Smokers.
Murphy SE; Sipe CJ; Choi K; Raddatz LM; Koopmeiners JS; Donny EC; Hatsukami DK
Cancer Epidemiol Biomarkers Prev; 2017 Jul; 26(7):1093-1099. PubMed ID: 28264876
[No Abstract] [Full Text] [Related]
30. Utility and relationships of biomarkers of smoking in African-American light smokers.
Ho MK; Faseru B; Choi WS; Nollen NL; Mayo MS; Thomas JL; Okuyemi KS; Ahluwalia JS; Benowitz NL; Tyndale RF
Cancer Epidemiol Biomarkers Prev; 2009 Dec; 18(12):3426-34. PubMed ID: 19959692
[TBL] [Abstract][Full Text] [Related]
31. CYP2A6 genotype and the metabolism and disposition kinetics of nicotine.
Benowitz NL; Swan GE; Jacob P; Lessov-Schlaggar CN; Tyndale RF
Clin Pharmacol Ther; 2006 Nov; 80(5):457-67. PubMed ID: 17112802
[TBL] [Abstract][Full Text] [Related]
32. Association of CYP2A6 activity with lung cancer incidence in smokers: The multiethnic cohort study.
Park SL; Murphy SE; Wilkens LR; Stram DO; Hecht SS; Le Marchand L
PLoS One; 2017; 12(5):e0178435. PubMed ID: 28542511
[TBL] [Abstract][Full Text] [Related]
33. Variation in CYP2A6 and nicotine metabolism among two American Indian tribal groups differing in smoking patterns and risk for tobacco-related cancer.
Tanner JA; Henderson JA; Buchwald D; Howard BV; Nez Henderson P; Tyndale RF
Pharmacogenet Genomics; 2017 May; 27(5):169-178. PubMed ID: 28181923
[TBL] [Abstract][Full Text] [Related]
34. Transferability of Ancestry-Specific and Cross-Ancestry CYP2A6 Activity Genetic Risk Scores in African and European Populations.
El-Boraie A; Chenoweth MJ; Pouget JG; Benowitz NL; Fukunaga K; Mushiroda T; Kubo M; Nollen NL; Sanderson Cox L; Lerman C; Knight J; Tyndale RF
Clin Pharmacol Ther; 2021 Oct; 110(4):975-985. PubMed ID: 33300144
[TBL] [Abstract][Full Text] [Related]
35. The contribution of common UGT2B10 and CYP2A6 alleles to variation in nicotine glucuronidation among European Americans.
Bloom AJ; von Weymarn LB; Martinez M; Bierut LJ; Goate A; Murphy SE
Pharmacogenet Genomics; 2013 Dec; 23(12):706-16. PubMed ID: 24192532
[TBL] [Abstract][Full Text] [Related]
36. Analyses of nicotine metabolism biomarker genetics stratified by sex in African and European Americans.
Chenoweth MJ; Cox LS; Nollen NL; Ahluwalia JS; Benowitz NL; Lerman C; Knight J; Tyndale RF
Sci Rep; 2021 Oct; 11(1):19572. PubMed ID: 34599228
[TBL] [Abstract][Full Text] [Related]
37. Nicotine metabolite ratio as an index of cytochrome P450 2A6 metabolic activity.
Dempsey D; Tutka P; Jacob P; Allen F; Schoedel K; Tyndale RF; Benowitz NL
Clin Pharmacol Ther; 2004 Jul; 76(1):64-72. PubMed ID: 15229465
[TBL] [Abstract][Full Text] [Related]
38. Nicotine metabolism: the impact of CYP2A6 on estimates of additive genetic influence.
Swan GE; Benowitz NL; Lessov CN; Jacob P; Tyndale RF; Wilhelmsen K
Pharmacogenet Genomics; 2005 Feb; 15(2):115-25. PubMed ID: 15861035
[TBL] [Abstract][Full Text] [Related]
39. CHRNA5-A3-B4 genetic variants alter nicotine intake and interact with tobacco use to influence body weight in Alaska Native tobacco users.
Zhu AZ; Renner CC; Hatsukami DK; Benowitz NL; Tyndale RF
Addiction; 2013 Oct; 108(10):1818-28. PubMed ID: 23692359
[TBL] [Abstract][Full Text] [Related]
40. A novel CYP2A6*20 allele found in African-American population produces a truncated protein lacking enzymatic activity.
Fukami T; Nakajima M; Higashi E; Yamanaka H; McLeod HL; Yokoi T
Biochem Pharmacol; 2005 Sep; 70(5):801-8. PubMed ID: 15993850
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
